{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:55Z","timestamp":1788273655143,"version":"build-2803163510"},"reference-count":125,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"R Luba and S Martinez","award":["NIDA T32 (DA007294-22"],"award-info":[{"award-number":["NIDA T32 (DA007294-22"]}]},{"name":"M Pravetoni and SD","award":["UG3DA047711"],"award-info":[{"award-number":["UG3DA047711"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/13543784.2023.2173062","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T19:57:16Z","timestamp":1674676636000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Immunotherapeutic strategies for treating opioid use disorder and overdose"],"prefix":"10.1080","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3404-766X","authenticated-orcid":false,"given":"Rachel","family":"Luba","sequence":"first","affiliation":[{"name":"New York State Psychiatric Institute\/Columbia University Irving Medical Center Division on Substance Use Disorders, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-8130","authenticated-orcid":false,"given":"Suky","family":"Martinez","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute\/Columbia University Irving Medical Center Division on Substance Use Disorders, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-2800","authenticated-orcid":false,"given":"Jermaine","family":"Jones","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute\/Columbia University Irving Medical Center Division on Substance Use Disorders, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-0184","authenticated-orcid":false,"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Washington, School of Medicine, Department of Psychiatry and Behavioral Sciences, Center for Medication Development for Substance Use Disorders and Overdose, Seattle WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-548X","authenticated-orcid":false,"given":"Sandra D","family":"Comer","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute\/Columbia University Irving Medical Center Division on Substance Use Disorders, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,12]]},"reference":[{"key":"cit0001","unstructured":"Abuse S. Key substance use and mental health indicators in the United States: results from the 2019 national survey on drug use and health 2020. Accessed at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf August 2022"},{"key":"cit0002","unstructured":"Centers for Disease Control and Prevention. State Unintentional Drug Overdose Reporting System (SUDORS). Atlanta, GA: US department of health and human services, CDC; [2022, June 27]. Accessed at: https:\/\/www.cdc.gov\/drugoverdose\/fatal\/dashboard"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.10452"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103392"},{"key":"cit0005","unstructured":"Tanz LJ, Dinwiddie AT, Snodgrass S, et al. Drug overdose deaths in 28 states and the District of Columbia: 2020 data from the state unintentional drug overdose reporting system 2022"},{"key":"cit0006","unstructured":"Centers for Disease Control and Prevention. Understanding the opioid overdose epidemic. Atlanta, GA: US department of health and human services, CDC; [2022, June 1]. Accessed at: https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html.August.2022"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"cit0008","unstructured":"IMS Institute for Healthcare Informatics. Use of opioid recovery medications. IMS institute for healthcare informatics [2016 September]. Accessed at: https:\/\/www.iqvia.com\/-\/media\/iqvia\/pdfs\/institute-reports\/use-of-opioid-recovery-medications.pdf.in.August.2022"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1111\/add.14886"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19060612"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.12.005"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.10.016"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.035"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"cit0015","volume-title":"The synthetic opioid surge in the United States. 2019 Santa Monica","author":"Pardo B"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103086"},{"key":"cit0017","unstructured":"US Drug Enforcement Administration. 2020 national drug threat assessment, DEA DCT-DIR-008\u201321. 2021. Available at: https:\/\/www.dea.gov\/documents\/2021\/03\/02\/2020-national-drug-threat-assessment. cited Aug 2022."},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.052"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12356"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1378577"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1212785"},{"key":"cit0022","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.208.Supp.123.12","volume":"208","author":"Crouse B","year":"2022","journal-title":"The Journal of Immunology"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y"},{"key":"cit0024","first-page":"77","volume-title":"Autoimmunity: from bench to bedside","author":"Cano RLE","year":"2013","edition":"1"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26109"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.06.001"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.281"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-18"},{"issue":"2","key":"cit0029","first-page":"205","volume":"7","author":"Chaudary S","year":"2020","journal-title":"An Public Health Res"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420118-7.00014-7"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100204"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500385"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1159\/000067433"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.64"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526285"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.02.004"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(03)00094-8"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0192-0561(00)00042-4"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1159\/000063629"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0027-2"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1586\/erv.13.13"},{"key":"cit0042","unstructured":"ClinicalTrials.Gov [Internet]. Bethesda (MD): National Library of Medicine. 2000 Feb 29. identifier nct00633321, study of TA-NIC to assess the efficacy and safety of a vaccine to aid in smoking cessation. and pharmacodynamics of SEL-068 vaccine in smokers and non-smokers, 2008, Mar 12 [cited Aug 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00633321"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntt003"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002547"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.007"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.317"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1080\/14622200701704921"},{"issue":"10","key":"cit0048","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/add.12291","volume":"108","author":"Hartmann-Boyce J","year":"2013","journal-title":"Addiction (Abingdon, England)"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076557"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.09.012"},{"key":"cit0051","unstructured":"ClinicalTrials.Gov [Internet]. Bethesda (MD): National Library of Medicine. 2000 Feb 29. Identifier NCT01478893, Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers, 2011, Nov 23 [cited Aug 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01478893"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.102"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1038\/378727a0"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1988"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.11.6202"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1129"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050049"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000555"},{"issue":"3","key":"cit0059","first-page":"789","volume":"296","author":"Koetzner L","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.28.1038"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1089\/humc.2013.231"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.114"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.200"},{"key":"cit0064","volume-title":"CPDD Annual Meeting","author":"Kosten TR","year":"2002"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.1.3.365"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.032"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.128"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.08.031"},{"key":"cit0069","unstructured":"ClinicalTrials.Gov [Internet]. Bethesda (MD): National Library of Medicine. 2000 Feb 29. Identifier NCT02455479, Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-Dependent Individuals, 2015, May 27 7 [cited Aug 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02455479"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.09.007"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12307"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05399-6"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.09.010"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.06.014"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1021\/ja108807j"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1039\/C4CC00682H"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00084"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.03.028"},{"issue":"2","key":"cit0079","first-page":"281","volume":"25","author":"Spector S","year":"1973","journal-title":"Pharmacol Rev"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1038\/252708a0"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.05.012"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-23150-1_4"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120098"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219159110"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184876"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1002\/ange.201511654"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107730"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00329-0"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00079"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.253674"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.1c00026"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c00820"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01427"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0013-9"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.02.006"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.013904"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.201194"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115696"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.247049"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1021\/jm3013745"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.6b00977"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.06.026"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101807"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23777-6"},{"issue":"2","key":"cit0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1470-8744.1999.tb00904.x","volume":"30","author":"Akbarzadeh A","year":"1999","journal-title":"Biotechnol Appl Biochem"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.3923\/jpt.2009.30.35"},{"key":"cit0107","unstructured":"ClinicalTrials.Gov [Internet]. Bethesda (MD): National Library of Medicine. 2000 Feb 29. Identifier NCT04458545, Clinical Trials of Multivalent Opioid Vaccine Components, 2020, Jul 7 [cited Aug 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04458545"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2003.11.029"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.004234"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2005.04.018"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.146407"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2006.01.008"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000124"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.212035"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.233510"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.119"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.4161\/19420862.2014.976431"},{"key":"cit0118","unstructured":"ClinicalTrials.Gov [Internet]. Bethesda (MD): National Library of Medicine. 2000 Feb 29. Identifier NCT03336866, Study of Antibody for Methamphetamine Outpatient Therapy (STAMPOUT), 2017, Nov 8 [cited Sept 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03336866"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.001048"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121094118"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00592"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1954442"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232086"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2016.1100960"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.015"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2023.2173062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T16:55:57Z","timestamp":1701795357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2023.2173062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/13543784.2023.2173062"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2023.2173062","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}